Category,Field_Name,Chinese_Name,Data_Type,Unit,Valid_Range,LOINC_Code,Required,Description,Clinical_Significance
Basic_Info,patient_id,患者ID,string,,,,,Y,唯一标识,患者追踪
Basic_Info,diagnosis_date,诊断日期,date,,,,,Y,确诊时间,疾病起点
Basic_Info,age,年龄,integer,years,18-120,,,Y,患者年龄,预后因素
Basic_Info,gender,性别,categorical,,Male,Female,,,Y,性别,流行病学
Basic_Info,smoking_history,吸烟史,categorical,,Never,Former,Current,,,Y,从不/戒烟/现吸,主要危险因素
Basic_Info,pack_years,吸烟包年,decimal,,0-200,,,N,吸烟量,暴露量化
Histology,histologic_type,组织学类型,categorical,,NSCLC_Adenocarcinoma,NSCLC_Squamous,NSCLC_Large_Cell,SCLC,Other,,,Y,腺癌/鳞癌/大细胞/小细胞/其他,治疗选择
Histology,differentiation,分化程度,categorical,,Well,Moderate,Poor,Undifferentiated,,,N,高/中/低/未分化,预后因素
Molecular,egfr_mutation,EGFR突变,categorical,,Negative,Exon19del,L858R,T790M,Other,,,Y,阴性/19外显子缺失/L858R/T790M/其他,靶向治疗
Molecular,alk_rearrangement,ALK重排,categorical,,Negative,Positive,,,N,阴性/阳性,克唑替尼适应证
Molecular,ros1_rearrangement,ROS1重排,categorical,,Negative,Positive,,,N,阴性/阳性,靶向治疗
Molecular,pdl1_expression,PD-L1表达,categorical,,Negative,1_to_49_percent,50_percent_or_higher,,,N,阴性/<1%/1-49%/≥50%,免疫治疗
Molecular,kras_mutation,KRAS突变,categorical,,Negative,G12C,Other,,,N,阴性/G12C/其他,新靶向药物
Molecular,braf_mutation,BRAF突变,categorical,,Negative,V600E,Other,,,N,阴性/V600E/其他,靶向治疗
TNM_Staging,clinical_t,临床T分期,categorical,,Tis,T1a,T1b,T1c,T2a,T2b,T3,T4,,,Y,原发肿瘤,解剖范围
TNM_Staging,clinical_n,临床N分期,categorical,,N0,N1,N2,N3,,,Y,区域淋巴结,转移评估
TNM_Staging,clinical_m,临床M分期,categorical,,M0,M1a,M1b,M1c,,,Y,远处转移,M1a胸腔/M1b单发/M1c多发
TNM_Staging,tnm_stage,TNM总分期,categorical,,IA1,IA2,IA3,IB,IIA,IIB,IIIA,IIIB,IIIC,IVA,IVB,,,Y,AJCC 8th,预后分层
Performance,ecog_ps,ECOG体能状态,integer,,0-5,89247-1,,Y,0-5分,治疗耐受性
Labs,cea,癌胚抗原,decimal,ng/mL,0-1000,2039-6,,N,CEA,肿瘤标志物
Labs,cyfra21_1,细胞角蛋白19片段,decimal,ng/mL,0-100,31163-6,,N,CYFRA21-1,鳞癌标志物
Labs,nse,神经元特异性烯醇化酶,decimal,ng/mL,0-100,9640-4,,N,NSE,小细胞肺癌标志物
Labs,scc_ag,鳞状细胞癌抗原,decimal,ng/mL,0-100,34677-8,,N,SCC,鳞癌标志物
Imaging,ct_chest_findings,胸部CT征象,string,,,,,Y,肿瘤大小位置,影像特征
Imaging,pet_suv_max,PET最大标准摄取值,decimal,,0-50,82668-8,,N,SUV max,代谢活性
Imaging,brain_mri,脑MRI,categorical,,Not_Done,Negative,Positive,,,N,未做/阴性/阳性,脑转移筛查
Imaging,bone_scan,骨扫描,categorical,,Not_Done,Negative,Positive,,,N,未做/阴性/阳性,骨转移筛查
Diagnosis,biopsy_method,活检方式,categorical,,Bronchoscopy,CT_Guided,Surgical,Liquid_Biopsy,,,Y,支气管镜/CT引导/手术/液体活检,诊断途径
Treatment_Surgery,surgical_procedure,手术方式,categorical,,Lobectomy,Pneumonectomy,Wedge_Resection,VATS,None,,,N,肺叶切除/全肺切除/楔形/VATS/无,根治性治疗
Treatment_Surgery,surgical_margins,切缘状态,categorical,,R0,R1,R2,,,N,阴性/镜下阳性/肉眼阳性,完全切除
Treatment_Surgery,lymph_nodes_examined,淋巴结检查数,integer,,0-100,,,N,病理检查淋巴结数,分期准确性
Treatment_Surgery,lymph_nodes_positive,阳性淋巴结数,integer,,0-100,,,N,转移淋巴结数,预后因素
Treatment_Systemic,chemotherapy_regimen,化疗方案,categorical,,Platinum_Pemetrexed,Platinum_Gemcitabine,Platinum_Etoposide,Other,None,,,N,铂类+培美/吉西/依托泊苷/其他/无,全身治疗
Treatment_Systemic,targeted_therapy,靶向治疗,categorical,,Osimertinib,Gefitinib,Erlotinib,Crizotinib,Alectinib,Ceritinib,None,,,N,奥希替尼/吉非替尼/厄洛替尼/克唑替尼/阿来替尼/色瑞替尼/无,精准治疗
Treatment_Systemic,immunotherapy,免疫治疗,categorical,,Pembrolizumab,Nivolumab,Atezolizumab,Durvalumab,None,,,N,帕博利珠单抗/纳武利尤单抗/阿替利珠单抗/度伐利尤单抗/无,免疫检查点抑制剂
Treatment_Radiation,radiation_therapy,放疗,categorical,,SBRT,Conventional,IMRT,Prophylactic_Cranial,None,,,N,SBRT/常规/调强/预防性全脑/无,局部治疗
Treatment_Radiation,radiation_dose,放疗剂量,decimal,Gy,0-100,,,N,总剂量,治疗强度
Response,treatment_response,治疗反应,categorical,,Complete_Response,Partial_Response,Stable_Disease,Progressive_Disease,,,N,完全缓解/部分缓解/疾病稳定/疾病进展,RECIST标准
Adverse_Events,treatment_toxicity,治疗毒性,categorical,,Grade_1,Grade_2,Grade_3,Grade_4,Grade_5,,,N,1-5级,CTCAE分级
Follow_Up,progression_free_survival,无进展生存期,integer,months,0-200,,,N,PFS,疗效指标
Follow_Up,overall_survival,总生存期,integer,months,0-200,,,N,OS,预后指标
Follow_Up,recurrence,复发,categorical,,No,Local,Distant,Both,,,N,无/局部/远处/两者,复发模式
Report,oncologist,肿瘤科医师,string,,,,,Y,主管医师,责任医师
Report,report_date,报告日期,date,,,,,Y,报告时间,文档记录
